Portfolio company
Boundless Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharma company develops precision medicines targeting extrachromosomal DNA to treat patients with oncogene amplified cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Acrivon Therapeutics
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Black Diamond Therapeutics
This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.
Frontier Medicines
This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.
IDEAYA Biosciences
This precision medicine company develops targeted oncology therapeutics for patients with solid tumours and molecularly defined cancers.
Kronos Bio
This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.
Profound Bio
This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.